We are live on ! Find out more
HC

Hampstead Capital Portfolio holdings

AUM $55.8M
1-Year Est. Return 2.76%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.7M
AUM Growth
+$2.4M
Cap. Flow
+$1.65M
Cap. Flow %
1.71%
Top 10 Hldgs %
49.68%
Holding
29
New
–
Increased
10
Reduced
7
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.19M
2
WLK icon
Westlake Corp
WLK
+$949K
3
GILD icon
Gilead Sciences
GILD
+$703K
4
XOM icon
ExxonMobil
XOM
+$501K
5
RRC icon
Range Resources
RRC
+$463K

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$963K
2
AAPL icon
Apple
AAPL
+$922K
3
HPE icon
Hewlett Packard
HPE
+$832K
4
PM icon
Philip Morris
PM
+$475K
5
PFE icon
Pfizer
PFE
+$386K

Sector Composition

Rank Sector Weight
1 Healthcare 28.49%
2 Communication Services 17.53%
3 Energy 12.54%
4 Technology 11.01%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
1
AT&T
T
$159B
$7.23M 7.48%
230,244
+8,606
+4% +$271K
PFE icon
2
Pfizer
PFE
$143B
$7.22M 7.47%
222,499
-12,227
-5% -$386K
VTRS icon
3
Viatris
VTRS
$20.4B
$5.07M 5.24%
130,000
– –
CELG
4
DELISTED
Celgene Corp
CELG
$4.98M 5.15%
40,000
– –
TMUS icon
5
T-Mobile US
TMUS
$185B
$4.52M 4.68%
70,000
– –
AAPL icon
6
Apple
AAPL
$4.54T
$4.31M 4.46%
120,000
-28,000
-19% -$922K
MSFT icon
7
Microsoft
MSFT
$3.45T
$3.95M 4.09%
60,000
– –
PXD
8
DELISTED
Pioneer Natural Resource Co.
PXD
$3.73M 3.85%
20,000
– –
TEVA icon
9
Teva Pharmaceuticals
TEVA
$40.8B
$3.53M 3.65%
110,000
+35,000
+47% +$1.19M
RRC icon
10
Range Resources
RRC
$9.38B
$3.49M 3.61%
120,000
+15,000
+14% +$463K
GILD icon
11
Gilead Sciences
GILD
$162B
$3.46M 3.58%
51,000
+10,000
+24% +$703K
GM icon
12
General Motors
GM
$80.4B
$3.36M 3.48%
95,000
– –
XOM icon
13
ExxonMobil
XOM
$644B
$3.29M 3.4%
40,100
+6,000
+18% +$501K
PM icon
14
Philip Morris
PM
$297B
$3.29M 3.4%
29,100
-4,600
-14% -$475K
SO icon
15
Southern Company
SO
$109B
$3.28M 3.39%
65,900
+3,200
+5% +$158K
MRK icon
16
Merck
MRK
$322B
$3.28M 3.39%
54,077
– –
PPL
17
PPL Corp
PPL
$26.5B
$3.27M 3.39%
87,600
-2,000
-2% -$71.5K
RY icon
18
Royal Bank of Canada
RY
$291B
$3.27M 3.38%
44,800
-300
-0.7% -$21.7K
VZ icon
19
Verizon
VZ
$195B
$3.25M 3.36%
66,600
+8,900
+15% +$447K
MOS icon
20
The Mosaic Company
MOS
$7.03B
$3.21M 3.32%
110,000
– –
WLK icon
21
Westlake Corp
WLK
$9.03B
$2.64M 2.73%
40,000
+15,000
+60% +$949K
AIG icon
22
American International
AIG
$41.7B
$2.5M 2.58%
40,000
-15,000
-27% -$963K
HPE icon
23
Hewlett Packard
HPE
$63.4B
$2.38M 2.46%
230,555
-61,940
-21% -$832K
GG
24
DELISTED
Goldcorp Inc
GG
$2.25M 2.32%
154,000
– –
TWX
25
DELISTED
Time Warner Inc
TWX
$1.95M 2.02%
20,000
– –
1
2

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
EIC
ENA Investment Capital London, United Kingdom $61.8M AUM
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
BOIA
Bush ODonnell Investment Advisors St Louis, Missouri $65.2M AUM 13.39% 1-Year Est. Return

Hampstead Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Hampstead Capital held 29 positions worth $96.7M, up 2.6% from $94.3M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Trading was light in Q1 2017: portfolio turnover was 0%. Hampstead Capital opened no new positions and made no exits, leaving the 29-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Energy.

  • Hampstead Capital added most to Teva Pharmaceuticals in Q1 2017, an estimated $1.19M increase.
  • Hampstead Capital's biggest Q1 2017 reduction was American International, cutting an estimated $963K.
  • Hampstead Capital's ten largest holdings make up 50% of its $96.7M portfolio in Q1 2017.
  • Hampstead Capital opened 0 new positions and closed 0 in Q1 2017.
  • Hampstead Capital's portfolio value rose 2.6% quarter-over-quarter to $96.7M.

Based on Hampstead Capital's 13F filing for Q1 2017, filed 15 May 2017.